SEARCH RESULTS for NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

Recent Patent Assignments Patent Assignments - March 2017

Patent(s) Assignor(s) Orig. Assignee(s) Assignee(s)

(X0) 11002820: Compounds or agents that inhibit and induce the formation of focal microvessel dilatations

(A1) 20050142066: Compounds or agents that inhibit and induce the formation of focal microvessel dilatations

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

(X0) 14174072: SIGNATURES AND PCDETERMINANTS ASSOCIATED WITH PROSTATE CANCER AND METHODS OF USE THEREOF

(A1) 20140235479: SIGNATURES AND PCDETERMINANTS ASSOCIATED WITH PROSTATE CANCER AND METHODS OF USE THEREOF

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

(X0) 12601052: COMPOSITIONS AND METHODS FOR CANCER GENE DISCOVERY

(A1) 20110030074: COMPOSITIONS AND METHODS FOR CANCER GENE DISCOVERY

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

(X0) 12442222: METHODS FOR TREATING MICA-RELATED DISORDERS

(A1) 20100111973: METHODS FOR TREATING MICA-RELATED DISORDERS

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

(X0) 11781148: MUC1-IKB KINASE COMPLEXES AND THEIR ACTIVITIES

(A1) 20080241125: MUC1-IKB KINASE COMPLEXES AND THEIR ACTIVITIES

(B2) 8129345: MUC1-IKB KINASE COMPLEXES AND THEIR ACTIVITIES

DANA-FARBER CANCER INSTITUTE

N/A

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

(X0) 13094624: MODULATION OF MUC1 ACTIVITY

(A1) 20150266938: MODULATION OF MUC1 ACTIVITY

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

(X0) 11883965: Telomerase RNA Subunit and Methods of Use Thereof

(A1) 20090047672: Telomerase RNA Subunit and Methods of Use Thereof

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

(X0) 10848094: PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE THEREOF

(A1) 20040242614: PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE THEREOF

(B2) 7119095: PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE THEREOF

DANA-FARBER CANCER INSTITUTE

N/A

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

(X0) 10824321: METHODS FOR SYNTHESIS OF DIARYLMETHANES

(A1) 20040267011: METHODS FOR SYNTHESIS OF DIARYLMETHANES

(B2) 7256197: METHODS FOR SYNTHESIS OF DIARYLMETHANES

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

N/A

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

(X0) 11027273: PHARMACEUTICALS AND METHODS FOR TREATING HYPOXIA AND SCREENING METHODS THEREFOR

(A1) 20050186650: PHARMACEUTICALS AND METHODS FOR TREATING HYPOXIA AND SCREENING METHODS THEREFOR

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

(X0) 11963152: Methods and Compositions for Modulating Gluconeogenesis Using PGC-1

(A1) 20080248475: Methods and Compositions for Modulating Gluconeogenesis Using PGC-1

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

(X0) 09658734: METHODS FOR IDENTIFYING COMPOUNDS WHICH MODULATE THE ACTIVITY OF MSH5

(B1) 7211375: METHODS FOR IDENTIFYING COMPOUNDS WHICH MODULATE THE ACTIVITY OF MSH5

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

N/A

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

(X0) 09615387: CLONING AND CHARACTERIZATION OF A CDC 15-LIKE ADAPTOR PROTEIN (CD2BP1)

(B1) 6689868: CLONING AND CHARACTERIZATION OF A CDC 15-LIKE ADAPTOR PROTEIN (CD2BP1)

DANA-FARBER CANCER INSTITUTE

N/A

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

(X0) 11126817: Intrabody-mediated control of immune reactions

(A1) 20060034834: Intrabody-mediated control of immune reactions

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR